Scientists at University College London have successfully grown functional esophagi in the lab and transplanted them into pigs, restoring the animals' ability to swallow and eat normally. The breakthrough, published in Nature Biotechnology, represents a major advance in tissue engineering—not just growing cells, but creating complex organs that actually work.
Paolo De Coppi, a pediatric surgeon and researcher leading the team, has been investigating better treatments for children born with long-gap esophageal atresia—a condition where a large section of the esophagus is missing. Current treatments are brutal: surgeons either move the child's stomach up to their neck and connect it directly to the throat, or transplant part of the colon to bridge the gap.
De Coppi's team took a different approach. They started with small samples of muscle cells and connective tissue from recipient pigs and turned them into stem cells. Separately, they took esophagi from donor pigs and stripped away all the original cells, leaving behind just the structural scaffold.
Then came the clever bit: they injected the recipient's own stem cells into the scaffold. Over two months, the cells grew across the framework, creating a fully personalized organ graft. The team used 10-kilogram minipigs—roughly approximating the size of children who might one day receive this treatment.
The surgeons removed 2.5-centimeter segments from eight recipient pigs and replaced them with the lab-grown tissue. Five pigs survived the full six-month study period. These animals showed functioning muscle, nerves, and blood vessels—and could swallow normally.
What's particularly impressive, notes Andrew Barbour, a surgeon at the University of Queensland, is that the grafts developed some scar tissue initially—a common problem that impairs swallowing—but this reduced over time. That suggests the engineered tissue can heal and remodel itself, much like natural tissue.
Now, before you get too excited: this is still animal research. The leap from 10-kilogram pigs to human children involves scaling challenges, immune considerations, and regulatory hurdles that could take years to navigate. Three of the eight pigs in the study had to be euthanized early for humane reasons, reminding us that the technique isn't perfected.
